The role of PET-CT fusion in head and neck cancer

ONCOLOGY

Volumn 19, Issue 2, 2005, Pages 241-246

  Rusthoven, Kyle E ^a   Koshy, Mary ^a   Paulino, Arnold C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; PLATINUM; DIAGNOSTIC AGENT;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HEALTH CARE PLANNING; HUMAN; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE DISTRIBUTION; REVIEW; SENSITIVITY AND SPECIFICITY; TONSIL TUMOR; UNIVERSITY HOSPITAL; CARCINOMA; HEAD AND NECK TUMOR; METHODOLOGY; PATIENT CARE PLANNING; RADIATION INJURY; RADIOGRAPHY; SCINTISCANNING;

CARCINOMA; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 19444376686     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Lardinois D, Weder W, Hany T, et al: Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500-2507, 2003.
2. Schechter NR, Gillenwater AM, Byers RM, et al: Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys 51:4-9, 2001.
3. Lowe VJ, Dunphy FR, Varvares M, et al: Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron-emission tomography. Head Neck 19:666-674, 1997.
4. Wolf G, Nicoletti R, Schultes G, et al: Preoperative image fusion of fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography data sets in oral maxillofacial carcinoma. J Comput Assist Tomogr 27:889-895, 2003.
5. Kao C, Shiau Y, Shen Y, et al: Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: Comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 94:1981-1986, 2002.
6. Piwnica-Worms D, Holman LB: Noncardiac application of hexakis (alkyl-isonitrile) technetium-99m complexes. J Nucl Med 31:1646-1653, 1990.
7. Henze M, Mohammed A, Mier W, et al: Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L- tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile. Eur J Nucl Med Mol Imaging 29:324-330, 2002.
8. Di Martino E, Nowak B, Hassan HA, et al: Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126:1457-1461, 2000.
9. Stokkel MP, ten Broek FW, Hordijk GJ, et al: Preoperative evaluation of patients with primary head and neck cancer using dual-head 18-fluorodeoxyglucose positron emission tomography. Ann Surg 231:229-234, 2000.
10. Hany T, Steinen C, Goerres G, et al: PET diagnostic accuracy: Improvement with in-line PET-CT system. Initial Res Radiol 225:575-581, 2002.
11. Wong W, Hussain K, Chevretton E, et al: Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 172:628-632, 1996.
12. Antoch G, Vogt FM, Freudenberg LS, et al: Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199-3206, 2003.
13. Zimny M, Wildberger JE, Cremerius U, et al: Combined image interpretation of computed tomography and hybrid PET in head and neck cancer (abstract). Nuklearmed 41:14-21, 2002.
14. Bar-Shalom R, Yefremov N, Guralnik L. et al: Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 44:1200-1209, 2003.
15. McGuirt WF, Greven KM, Williams DW 3rd, et al: PET scanning in head and neck oncology: A review. Head Neck 20:208-215, 1998.
16. Schoder H, Yeung HW, Gonen M, et al: Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 231:65-72, 2004.
17. Keys JW Jr, Watson NE Jr, Williams DW 3rd, et al: FDG-PET in head and neck cancer. AJR Am J Roentgenol 169:1663-1669, 1997.
18. Kiffer JD, Berlangieri SU, Scott AM, et al: The contribution of 18F-fluoro-2-deoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19:167-177, 1998.
19. Nestle U, Walter K, Schmidt S, et al: 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44:593-597, 1999.
20. Erdi YE, Rosenzweig K, Erdi AK, et al: Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62:51-60, 2002.
21. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al: The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55:317-324, 2000.
22. Mah K, Caldwell CB, Ung YC, et al; The impact of (18) FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52:339-350, 2002.
23. Kalff V, Hicks RJ, MacManus MP, et al: Clinical impact of (18) fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study. J Clin Oncol 19:111-118, 2001.
24. Nishioka T, Shiga T, Shirato H, et al: Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53:1051-1057, 2002.
25. Daisne J, Duprez T, Weynant B, et al: Impact of image coregistration with computed tomography (CT), magnetic resonance (MR), and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTVs in oropharyngeal, laryngeal and hypopharyngeal tumors. Int J Radiat Oncol Biol Phys 54(S):15-16, 2002.
26. Ciernik F, Dizendorf E, Baumert B, et al: Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57:853-863, 2003.
27. Goerres GW, Hany TF, Kamel E, et al: Head and neck imaging with PET and PET/CT: Artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging 29:367-370, 2002.
28. Daisne JF, Sibomana M, Bol A, et al: Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: Accuracy, reproducibility and consistency. Radiother Oncol 69:237-245, 2003.